The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
You forget Edinburgh which has a valuable freehold site.
Losses year after year is unsustainable.
Very positive news for a £2m market cap company. The upside potential is large indeed.
Must be due a trading update soon.
The pharma that moves first will get the rewards.
Nuvec looks like the real deal.
Cash at hand tight?
20,000 followers for Discount Dragons as of today; that is a near 70% growth in just the last three months. Impressive.
Full year financial results for HUD ought to be due in 5/6 weeks, I will be looking for an encouraging update on current trading.
If Nuvec could be licensed out to a large Indian pharma company and taken/financed through trials, that would be a sizeable coup for N4p.
I expect we may get an update on Lets Explore and Vodiac soon. Could they be spun off as a separate vehicle? No clues at present, other than the CEO wanting to make sales of these products a year round educational/entertainment business.
Virtual reality products are gaining in popularity, especially after Apple Vision Pro launch. There is a lot of potential in this part of the business.
Discount Dragon continues to perform well it seems. The fulfilment time in order processing is noticeably faster . The product offerings has broadened markedly and quarter over quarter growth in sales will surely look impressive. The question remains re the bottom line and the cost of sales.
Stripping away the sizeable cash position, the stock market valuation looks undemanding for HUD.
N4p received patent award for Nuvec in India, announced not long ago, may have something to do with it.